These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26011730)
21. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation. Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020 [TBL] [Abstract][Full Text] [Related]
23. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors. Backus LI; Sharp T; Grahame-Smith DG Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051 [TBL] [Abstract][Full Text] [Related]
24. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. Smith BN; Sollars PJ; Dudek FE; Pickard GE J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775 [TBL] [Abstract][Full Text] [Related]
25. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study. Lacivita E; Podlewska S; Speranza L; Niso M; Satała G; Perrone R; Perrone-Capano C; Bojarski AJ; Leopoldo M Eur J Med Chem; 2016 Sep; 120():363-79. PubMed ID: 27318552 [TBL] [Abstract][Full Text] [Related]
26. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438 [TBL] [Abstract][Full Text] [Related]
27. Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Ryan BC; Young NB; Crawley JN; Bodfish JW; Moy SS Behav Brain Res; 2010 Mar; 208(1):178-88. PubMed ID: 19941908 [TBL] [Abstract][Full Text] [Related]
28. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131 [TBL] [Abstract][Full Text] [Related]
29. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice. Rajagopal L; Massey BW; Michael E; Meltzer HY Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
31. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice. Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981 [TBL] [Abstract][Full Text] [Related]
32. The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice. Shahidi S; Hashemi-Firouzi N Neurosci Lett; 2014 Aug; 578():27-32. PubMed ID: 24954075 [TBL] [Abstract][Full Text] [Related]
33. Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome. Haberzettl R; Fink H; Bert B J Pharmacol Toxicol Methods; 2014; 70(2):129-33. PubMed ID: 25087754 [TBL] [Abstract][Full Text] [Related]
34. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925 [TBL] [Abstract][Full Text] [Related]
35. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229 [TBL] [Abstract][Full Text] [Related]
36. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Silverman JL; Smith DG; Rizzo SJ; Karras MN; Turner SM; Tolu SS; Bryce DK; Smith DL; Fonseca K; Ring RH; Crawley JN Sci Transl Med; 2012 Apr; 4(131):131ra51. PubMed ID: 22539775 [TBL] [Abstract][Full Text] [Related]
37. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Scorza MC; Castañé A; Bortolozzi A; Artigas F Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811 [TBL] [Abstract][Full Text] [Related]
38. 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms. Carey RJ; De Palma G; Damianopoulos E Behav Brain Res; 2002 Apr; 132(1):37-46. PubMed ID: 11853856 [TBL] [Abstract][Full Text] [Related]
39. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. de Boer SF; Koolhaas JM Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183 [TBL] [Abstract][Full Text] [Related]